ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The T-cell-specific cell-surface receptors CD28 and CTLA-4 are important regulators of the immune system. CD28 potently enhances those T-cell functions that are essential for an effective antigen-specific immune response, and the homologous CTLA-4 counterbalances the CD28-mediated signals and thus prevents an otherwise fatal overstimulation of the lymphoid system. Here we report the identification of a third member of this family of molecules, inducible co-stimulator (ICOS), which is a homodimeric protein of relative molecular mass 55,000-60,000 (M(r) 55K-60K). Matching CD28 in potency, ICOS enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, upregulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B cells. Unlike the constitutively expressed CD28, ICOS has to be de novo induced on the T-cell surface, does not upregulate the production of interleukin-2, but superinduces the synthesis of interleukin-10, a B-cell-differentiation factor. In vivo, ICOS is highly expressed on tonsillar T cells, which are closely associated with B cells in the apical light zone of germinal centres, the site of terminal B-cell maturation. Our results indicate that ICOS is another major regulator of the adaptive immune system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune co-stimulator (ICOS) is a co-stimulatory molecule expressed on T cells, which enhances function and expansion of CD8+ T cells and Tregs (Fu et al., 2011; Hutloff et al., 1999; Liakou et al., 2008).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Hutloff et al., 1999
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.381 · Cited by 2,254
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
MacLennan, I. C. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.117 · Cited by 1,729
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239 · cited 1×
“Protein material from five gels was pooled, in situ -digested with trypsi”
Method
Cited by
Items 101–200 of 1,001
ICOS is critical for T helper cell–mediated lung mucosal inflammatory responses
Gonzalo, J. A., Tian, J., Delaney, T., Corcoran, J., Rottman, J. B., Lora, J., Al-garawi, A., Kroczek, R., Gutierrez-Ramos, J. C., & Coyle, A. J. (2001) · Nature Immunology · doi:10.1038/89739 · Cited by 279
Self-citationThe costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE
Rottman, J. B., Smith, T., Tonra, J. R., Ganley, K., Bloom, T., Silva, R., Pierce, B., Gutierrez-Ramos, J.-C., Özkaynak, E., & Coyle, A. J. (2001) · Nature Immunology · doi:10.1038/89750 · Cited by 273
VSIG4, a B7 family-related protein, is a negative regulator of T cell activation
Vogt, L., Schmitz, N., Kurrer, M. O., Bauer, M., Hinton, H. I., Behnke, S., Gatto, D., Sebbel, P., Beerli, R. R., Sonderegger, I., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25673 · Cited by 272
ICOS Controls the Pool Size of Effector-Memory and Regulatory T Cells
Burmeister, Y., Lischke, T., Dahler, A. C., Mages, H. W., Lam, K.-P., Coyle, A. J., Kroczek, R. A., & Hutloff, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.774 · Cited by 267
Self-citationAdvances in targeting cell surface signalling molecules for immune modulation
Yao, S., Zhu, Y., & Chen, L. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3877 · Cited by 267
Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS
Wang, S., Zhu, G., Chapoval, A. I., Dong, H., Tamada, K., Ni, J., & Chen, L. (2000) · Blood · doi:10.1182/blood.v96.8.2808 · Cited by 257
Signaling pathways in Th2 development
Mowen, K. A., & Glimcher, L. H. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00209.x · Cited by 255
The Inducible Costimulator (ICOS) Is Critical for the Development of Human T H 17 Cells
Paulos, C. M., Carpenito, C., Plesa, G., Suhoski, M. M., Varela-Rohena, A., Golovina, T. N., Carroll, R. G., Riley, J. L., & June, C. H. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000448 · Cited by 255
Löhning, M., Hutloff, A., Kallinich, T., Mages, H. W., Bonhagen, K., Radbruch, A., Hamelmann, E., & Kroczek, R. A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020632 · Cited by 253
Self-citationA PD‐1 polymorphism is associated with disease progression in multiple sclerosis
Kroner, A., Mehling, M., Hemmer, B., Rieckmann, P., Toyka, K. V., Mäurer, M., & Wiendl, H. (2005) · Annals of Neurology · doi:10.1002/ana.20514 · Cited by 249
Structure and Dimerization of a Soluble Form of B7-1
Ikemizu, S., Gilbert, R. J. C., Fennelly, J. A., Collins, A. V., Harlos, K., Jones, E. Y., Stuart, D. I., & Davis, S. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)80158-2 · Cited by 249
Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells
Hubo, M., Trinschek, B., Kryczanowsky, F., Tuettenberg, A., Steinbrink, K., & Jonuleit, H. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00082 · Cited by 246
“ICOS-Ligand ICOS is expressed on CD4 T cells upon T cell receptor-mediated activation (Hutloff et al., 1999) and specifically interacts with ICOS-Ligand (ICOSL; B7-H2) on antigen-presenting cells (Yoshinaga et al.”
BackgroundT‐cell tolerance or function is determined by combinatorial costimulatory signals
Nurieva, R., Thomas, S., Nguyen, T., Martin‐Orozco, N., Wang, Y., Kaja, M., Yu, X., & Dong, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601146 · Cited by 245
Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
Callahan, M. K., Wolchok, J. D., & Allison, J. P. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.09.001 · Cited by 245
Role for IL-10 in Suppression Mediated by Peptide-Induced Regulatory T Cells In Vivo
Sundstedt, A., O’Neill, E. J., Nicolson, K. S., & Wraith, D. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1240 · Cited by 245
Characterization of Human Inducible Costimulator Ligand Expression and Function
Aicher, A., Hayden-Ledbetter, M., Brady, W. A., Pezzutto, A., Richter, G., Magaletti, D., Buckwalter, S., Ledbetter, J. A., & Clark, E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4689 · Cited by 245
The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti–CTLA-4 Therapy
Fu, T., He, Q., & Sharma, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1138 · Cited by 243
Molecular and Cellular Functions of CTLA-4
Van Coillie, S., Wiernicki, B., & Xu, J. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3266-5_2 · Cited by 243
Programmed Death-1 Targeting Can Promote Allograft Survival
Özkaynak, E., Wang, L., Goodearl, A., McDonald, K., Qin, S., O’Keefe, T., Duong, T., Smith, T., Gutierrez-Ramos, J.-C., Rottman, J. B., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6546 · Cited by 243
Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase
Gigoux, M., Shang, J., Pak, Y., Xu, M., Choe, J., Mak, T. W., & Suh, W.-K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911573106 · Cited by 241
Cancer immunotherapy: broadening the scope of targetable tumours
van den Bulk, J., Verdegaal, E. M., & de Miranda, N. F. (2018) · Open Biology · doi:10.1098/rsob.180037 · Cited by 240
Khayyamian, S., Hutloff, A., Büchner, K., Gräfe, M., Henn, V., Kroczek, R. A., & Mages, H. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092576699 · Cited by 236
Self-citationRegulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)
Simpson, T. R., Quezada, S. A., & Allison, J. P. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.001 · Cited by 233
“ICOS regulates CD4 Tfh control of B cell function ICOS was first identified on the cell surface of germinal center T cells, pointing to its potential role in T cell–B cell interactions [2].”
BackgroundLing, V., Wu, P. W., Finnerty, H. F., Bean, K. M., Spaulding, V., Fouser, L. A., Leonard, J. P., Hunter, S. E., Zollner, R., Thomas, J. L., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1653 · Cited by 230
Targeting co-stimulatory molecules in autoimmune disease
Edner, N. M., Carlesso, G., Rush, J. S., & Walker, L. S. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0081-9 · Cited by 228
Rolf, J., Bell, S. E., Kovesdi, D., Janas, M. L., Soond, D. R., Webb, L. M. C., Santinelli, S., Saunders, T., Hebeis, B., Killeen, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001730 · Cited by 227
New regulatory co-receptors: inducible co-stimulator and PD-1
Okazaki, T., Iwai, Y., & Honjo, T. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00398-9 · Cited by 226
T‐cell costimulatory pathways in allograft rejection and tolerance
Rothstein, D. M., & Sayegh, M. H. (2003) · Immunological Reviews · doi:10.1046/j.1600-065x.2003.00088.x · Cited by 222
Oh, J.-W., Seroogy, C. M., Meyer, E. H., Akbari, O., Berry, G., Fathman, C. G., DeKruyff, R. H., & Umetsu, D. T. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.127512 · Cited by 219
Chen, H., Liakou, C. I., Kamat, A., Pettaway, C., Ward, J. F., Tang, D. N., Sun, J., Jungbluth, A. A., Troncoso, P., Logothetis, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813175106 · Cited by 218
Faget, J., Bendriss-Vermare, N., Gobert, M., Durand, I., Olive, D., Biota, C., Bachelot, T., Treilleux, I., Goddard-Leon, S., Lavergne, E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2409 · Cited by 217
“Identified in 1999 (18), ICOS, a T cell costimulatory molecule of the CTLA4/PD1/CD28 family, plays a nonoverlapping function with CD28 (19) on CD4þ T cells.”
BackgroundMolecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome
Lee, W.-I., Torgerson, T. R., Schumacher, M. J., Yel, L., Zhu, Q., & Ochs, H. D. (2005) · Blood · doi:10.1182/blood-2003-12-4420 · Cited by 217
Kumar, P., Bhattacharya, P., & Prabhakar, B. S. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.08.007 · Cited by 216
Dong, C., & Flavell, R. A. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200101000-00009 · Cited by 216
New insights into the differentiation and function of T follicular helper cells
King, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2644 · Cited by 215
“The expression of multiple co-stimulatory molecules is a feature of T FH cells, which may reflect both the sustained multi-signal integration required for their generation and their unique association with B cell”
BackgroundMolecular and cellular pathogenesis of X‐linked lymphoproliferative disease
Nichols, K. E., Ma, C. S., Cannons, J. L., Schwartzberg, P. L., & Tangye, S. G. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00230.x · Cited by 215
The expanding world of co-stimulation: the two-signal model revisited
Chambers, C. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01868-3 · Cited by 214
Fas Receptor Expression in Germinal-Center B Cells Is Essential for T and B Lymphocyte Homeostasis
Hao, Z., Duncan, G. S., Seagal, J., Su, Y.-W., Hong, C., Haight, J., Chen, N.-J., Elia, A., Wakeham, A., Li, W. Y., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.016 · Cited by 212
Current Perspectives in Cancer Immunotherapy
Christofi, T., Baritaki, S., Falzone, L., Libra, M., & Zaravinos, A. (2019) · Cancers · doi:10.3390/cancers11101472 · Cited by 210
“1/2), ICOS and ICOS-L, CD27 and CD70, 4-1BB and 4-1BB-L, CD47 and SIRPa or MHC-1 and CD94/NKG2A, among other (Figure 1).”
BackgroundInfluentialMak, T. W., Shahinian, A., Yoshinaga, S. K., Wakeham, A., Boucher, L.-M., Pintilie, M., Duncan, G., Gajewska, B. U., Gronski, M., Eriksson, U., et al. (2003) · Nature Immunology · doi:10.1038/ni947 · Cited by 209
“ICOS is homologous to CD28 but is expressed on T cells only after activatio”
BackgroundCutting Edge: Critical Role of Inducible Costimulator in Germinal Center Reactions
Dong, C., Temann, U.-A., & Flavell, R. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3659 · Cited by 209
The Roles of the New Negative T Cell Costimulatory Pathways in Regulating Autoimmunity
Khoury, S. J., & Sayegh, M. H. (2004) · Immunity · doi:10.1016/s1074-7613(04)00116-5 · Cited by 209
Perales, M.-A., Goldberg, J. D., Yuan, J., Koehne, G., Lechner, L., Papadopoulos, E. B., Young, J. W., Jakubowski, A. A., Zaidi, B., Gallardo, H., et al. (2012) · Blood · doi:10.1182/blood-2012-06-437236 · Cited by 208
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
Zhao, R., Chinai, J. M., Buhl, S., Scandiuzzi, L., Ray, A., Jeon, H., Ohaegbulam, K. C., Ghosh, K., Zhao, A., Scharff, M. D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303524110 · Cited by 208
Freitas do Rosário, A. P., Lamb, T., Spence, P., Stephens, R., Lang, A., Roers, A., Muller, W., O’Garra, A., & Langhorne, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102755 · Cited by 207
Kopf, M., Coyle, A. J., Schmitz, N., Barner, M., Oxenius, A., Gallimore, A., Gutierrez-Ramos, J.-C., & Bachmann, M. F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.53 · Cited by 206
Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy
Ng Tang, D., Shen, Y., Sun, J., Wen, S., Wolchok, J. D., Yuan, J., Allison, J. P., & Sharma, P. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0020 · Cited by 203
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis
Kaczanowska, S., Beury, D. W., Gopalan, V., Tycko, A. K., Qin, H., Clements, M. E., Drake, J., Nwanze, C., Murgai, M., Rae, Z., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.048 · Cited by 203
Invariant Vα19i T cells regulate autoimmune inflammation
Croxford, J. L., Miyake, S., Huang, Y.-Y., Shimamura, M., & Yamamura, T. (2006) · Nature Immunology · doi:10.1038/ni1370 · Cited by 203
Pentcheva‐Hoang, T., Corse, E., & Allison, J. P. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00763.x · Cited by 203
Hutloff, A., Büchner, K., Reiter, K., Baelde, H. J., Odendahl, M., Jacobi, A., Dörner, T., & Kroczek, R. A. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20519 · Cited by 201
Self-citationICOS deficiency in patients with common variable immunodeficiency
Salzer, U., Maul-Pavicic, A., Cunningham-Rundles, C., Urschel, S., Belohradsky, B. H., Litzman, J., Holm, A., Franco, J. L., Plebani, A., Hammarstrom, L., et al. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.07.002 · Cited by 201
Costimulatory pathways in transplantation: challenges and new developments
Li, X. C., Rothstein, D. M., & Sayegh, M. H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00781.x · Cited by 197
Increased Frequency of Follicular Helper T Cells in Patients with Autoimmune Thyroid Disease
Zhu, C., Ma, J., Liu, Y., Tong, J., Tian, J., Chen, J., Tang, X., Xu, H., Lu, L., & Wang, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2003 · Cited by 196
BTNL2, a Butyrophilin-Like Molecule That Functions to Inhibit T Cell Activation
Nguyen, T., Liu, X. K., Zhang, Y., & Dong, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7354 · Cited by 195
Zhang, G., Hou, J., Shi, J., Yu, G., Lu, B., & Zhang, X. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02723.x · Cited by 192
The Art of War: Innate and adaptive immune responses
Dempsey, P. W., Vaidya, S. A., & Cheng, G. (2003) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-003-3180-y · Cited by 190
Sanmamed, M. F., Pastor, F., Rodriguez, A., Perez-Gracia, J. L., Rodriguez-Ruiz, M. E., Jure-Kunkel, M., & Melero, I. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.05.014 · Cited by 190
Taming cancer by inducing immunity via dendritic cells
Palucka, A. K., Ueno, H., Fay, J. W., & Banchereau, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00575.x · Cited by 189
Neidleman, J., Luo, X., Frouard, J., Xie, G., Gill, G., Stein, E. S., McGregor, M., Ma, T., George, A. F., Kosters, A., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100081 · Cited by 188
“Some cTfh cells also express high levels of ICOS, a co-stimulatory molecule that plays a critical role in Tfh function, including helping with development of high-affinity B cells.(26) We found that SARS-CoV-2-specific CD4+ T cells expressed especially high levels of ICOS, suggesting an active helper function of B cel…”
BackgroundThe role of B7 family molecules in hematologic malignancy
Greaves, P., & Gribben, J. G. (2013) · Blood · doi:10.1182/blood-2012-10-385591 · Cited by 187
Flexible migration program regulates γδ T-cell involvement in humoral immunity
Brandes, M., Willimann, K., Lang, A. B., Nam, K.-H., Jin, C., Brenner, M. B., Morita, C. T., & Moser, B. (2003) · Blood · doi:10.1182/blood-2003-04-1016 · Cited by 185
Hurchla, M. A., Sedy, J. R., Gavrielli, M., Drake, C. G., Murphy, T. L., & Murphy, K. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3377 · Cited by 181
Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy
Burton, B. R., Britton, G. J., Fang, H., Verhagen, J., Smithers, B., Sabatos-Peyton, C. A., Carney, L. J., Gough, J., Strobel, S., & Wraith, D. C. (2014) · Nature Communications · doi:10.1038/ncomms5741 · Cited by 181
Crystal structure of a soluble CD28-Fab complex
Evans, E. J., Esnouf, R. M., Manso-Sancho, R., Gilbert, R. J. C., James, J. R., Yu, C., Fennelly, J. A., Vowles, C., Hanke, T., Walse, B., et al. (2005) · Nature Immunology · doi:10.1038/ni1170 · Cited by 180
Induction, binding specificity and function of human ICOS
Beier, K. C., Hutloff, A., Dittrich, A., Heuck, C. J., Rauch, A. M., Büchner, K., Ludewig, B., Ochs, H. D., Mages, H. W., & Kroczek, R. A. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200012)30:12<3707::aid-immu3707>3.0.co;2-q · Cited by 208
Self-citationWang, C. J., Heuts, F., Ovcinnikovs, V., Wardzinski, L., Bowers, C., Schmidt, E. M., Kogimtzis, A., Kenefeck, R., Sansom, D. M., & Walker, L. S. K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414576112 · Cited by 179
Exploration of microRNAs in porcine milk exosomes
Chen, T., Xi, Q.-Y., Ye, R.-S., Cheng, X., Qi, Q.-E., Wang, S.-B., Shu, G., Wang, L.-N., Zhu, X.-T., Jiang, Q.-Y., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-100 · Cited by 179
The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
Solinas, C., Gu-Trantien, C., & Willard-Gallo, K. (2020) · ESMO Open · doi:10.1136/esmoopen-2019-000544 · Cited by 177
Effects of tumor metabolic microenvironment on regulatory T cells
Wang, Y.-A., Li, X.-L., Mo, Y.-Z., Fan, C.-M., Tang, L., Xiong, F., Guo, C., Xiang, B., Zhou, M., Ma, J., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0913-y · Cited by 176
Mechanism of Action of Immunotherapy
Disis, M. L. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.09.004 · Cited by 175
Burt, R. K. (2002) · Blood · doi:10.1182/blood.v99.3.768 · Cited by 175
The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation
Yamada, A., Salama, A. D., & Sayegh, M. H. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132559 · Cited by 174
Ma, C. S., Hare, N. J., Nichols, K. E., Dupré, L., Andolfi, G., Roncarolo, M.-G., Adelstein, S., Hodgkin, P. D., & Tangye, S. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523139 · Cited by 172
Zagorulya, M., Yim, L., Morgan, D. M., Edwards, A. W., Torres-Mejia, E., Momin, N., McCreery, C. V., Zamora, I., Horton, B. L., Fox, J. G., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.010 · Cited by 176
Osteopontin at the Crossroads of Inflammation and Tumor Progression
Castello, L. M., Raineri, D., Salmi, L., Clemente, N., Vaschetto, R., Quaglia, M., Garzaro, M., Gentilli, S., Navalesi, P., Cantaluppi, V., et al. (2017) · Mediators of Inflammation · doi:10.1155/2017/4049098 · Cited by 170
Verstappen, G. M., Meiners, P. M., Corneth, O. B. J., Visser, A., Arends, S., Abdulahad, W. H., Hendriks, R. W., Vissink, A., Kroese, F. G. M., & Bootsma, H. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40165 · Cited by 170
“5 molecules essential for interaction with B-cells, including PD-1 and ICOS (10,11).”
BackgroundParry, R. V., Rumbley, C. A., Vandenberghe, L. H., June, C. H., & Riley, J. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.166 · Cited by 169
Strauss, L., Bergmann, C., Szczepanski, M. J., Lang, S., Kirkwood, J. M., & Whiteside, T. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2967 · Cited by 165
B7-H2 Is a Costimulatory Ligand for CD28 in Human
Yao, S., Zhu, Y., Zhu, G., Augustine, M., Zheng, L., Goode, D. J., Broadwater, M., Ruff, W., Flies, S., Xu, H., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.014 · Cited by 153
Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy
Gaikwad, S. R., Agrawal, M. Y., Kaushik, I., Ramachandran, S., & Srivastava, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.014 · Cited by 172
IL-12 receptor β1 deficiency alters in vivo T follicular helper cell response in humans
Schmitt, N., Bustamante, J., Bourdery, L., Bentebibel, S. E., Boisson-Dupuis, S., Hamlin, F., Tran, M. V., Blankenship, D., Pascual, V., Savino, D. A., et al. (2013) · Blood · doi:10.1182/blood-2012-08-448902 · Cited by 163
Negative co-receptors on lymphocytes
Greenwald, R. J., Latchman, Y. E., & Sharpe, A. H. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00341-2 · Cited by 163
ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases
Li, D.-Y., & Xiong, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02104 · Cited by 172
“ICOS and CD28 As a member of the CD28 family, human ICOS is a type-I transmembrane protein that shares 24% identity with CD28 and 17% identity with CTLA-4 (1).”
BackgroundTakahashi, N., Matsumoto, K., Saito, H., Nanki, T., Miyasaka, N., Kobata, T., Azuma, M., Lee, S., Mizutani, S., & Morio, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803256 · Cited by 173
The contribution of immunology to the rational design of novel antibacterial vaccines
Kaufmann, S. H. E. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1688 · Cited by 186
“The inducible T-cell co-stimulator ( ICOS ) molecule is found on memory T cells and effector T cells and, therefore, by interacting with its co-receptor ICOS-L on professional APCs, has an important role in T-cell activation and differentiatio”
BackgroundCaccamo, N., Battistini, L., Bonneville, M., Poccia, F., Fournié, J. J., Meraviglia, S., Borsellino, G., Kroczek, R. A., La Mendola, C., Scotet, E., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5290 · Cited by 161
Self-citationThe elusive identity of T follicular helper cells
Yu, D., & Vinuesa, C. G. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.07.001 · Cited by 161
The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells
Nakazawa, A., Dotan, I., Brimnes, J., Allez, M., Shao, L., Tsushima, F., Azuma, M., & Mayer, L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.004 · Cited by 160
Targeting co-stimulatory pathways: transplantation and autoimmunity
Ford, M. L., Adams, A. B., & Pearson, T. C. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.183 · Cited by 157
Deenick, E. K., Gett, A. V., & Hodgkin, P. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4963 · Cited by 159
Linterman, M. A., Rigby, R. J., Wong, R. K., Silva, D., Withers, D. R., Anderson, G., Verma, N. K., Brink, R. A., Hutloff, A., Goodnow, C. C., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.015 · Cited by 172
Self-citationFlowcytometric phenotyping of common variable immunodeficiency
Warnatz, K., & Schlesier, M. (2008) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20432 · Cited by 158
New therapies for systemic lupus erythematosus — past imperfect, future tense
Murphy, G., & Isenberg, D. A. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0235-5 · Cited by 158
TH1 and TH2 Lymphocyte Development and Regulation of TH Cell–Mediated Immune Responses of the Skin
Biedermann, T., Röcken, M., & Carballido, J. M. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2004.00829.x · Cited by 175
Yin–Yang of costimulation: crucial controls of immune tolerance and function
Nurieva, R. I., Liu, X., & Dong, C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00769.x · Cited by 157
“A Rose is a Rose is a Rose,” but CVID is Not CVID
Yong, P. F. K., Thaventhiran, J. E. D., & Grimbacher, B. (2011) · Advances in immunology · doi:10.1016/b978-0-12-385991-4.00002-7 · Cited by 160
Pathogenic role of the CXCL16–CXCR6 pathway in rheumatoid arthritis
Nanki, T., Shimaoka, T., Hayashida, K., Taniguchi, K., Yonehara, S., & Miyasaka, N. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21301 · Cited by 169
Enhancement of CD8+ T Cell Responses by ICOS/B7h Costimulation
Wallin, J. J., Liang, L., Bakardjiev, A., & Sha, W. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.132 · Cited by 155
Regulatory T cells in the tumour microenvironment
Imianowski, C. J., Chen, Q., Workman, C. J., & Vignali, D. A. A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00832-9 · Cited by 159
“ICOS (inducible T cell co-stimulator) is a member of the CD28 superfamily, which is implicated in the secretion of IL-10 and TGFβ in T cells 133,134 .”
Metadata
- Authors
- Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A.
- Affiliations
- Robert Koch Institute (DE)
- Max Delbrück Center (DE)
- Freie Universität Berlin (DE)
- Corresponding author
- Kroczek, Richard A.
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6716
- Pages
- 263-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1661441964
- Cited by
- 1,482
- References
- 30
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 52 · 2023: 41 · 2022: 66 · 2021: 54 · 2020: 60 · 2019: 53 · 2018: 52 · 2017: 32 · 2016: 44 · 2015: 41 · 2014: 35 · 2013: 53 · 2012: 47
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- ICOS, CD28, CTLA-4, T cell costimulation, T cell proliferation, lymphokine secretion, IL-10, B cell help, germinal center, adaptive immune regulation
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Cell Communication, Cell Line, Cloning, Molecular, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Molecular Sequence Data, T-Lymphocytes, CD28 Antigens, Germinal Center, Mice, Inducible T-Cell Co-Stimulator Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.